HPA007859

antibody from Atlas Antibodies

Targeting: FNDC3B DKFZp762K137, FAD104, FLJ23399, PRO4979, YVTM2421

Western blot (Data presented on provider website)

Immunocytochemistry (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

HPA007859

Provider

Atlas Antibodies

Proper citation

Atlas Antibodies Cat#HPA007859, RRID:AB_1078900

Product name

Anti-FNDC3B

Antibody type

Polyclonal

Description

Polyclonal Antibody against Human FNDC3B, Gene description: fibronectin type III domain containing 3B, Alternative Gene Names: DKFZp762K137, FAD104, FLJ23399, PRO4979, YVTM2421, Validated applications: WB, IHC, ICC, Uniprot ID: Q53EP0, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.

Reactivity

Human, Mouse, Rat

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

100 µl

Concentration

0.1 mg/ml

Storage

Store at +4°C for short term storage. Long time storage is recommended at -20°C.

Handling

The antibody solution should be gently mixed before use.

References

Submitted references

Isoflurane upregulates microRNA-9-3p to protect rats from hepatic ischemia-reperfusion injury through inhibiting fibronectin type III domain containing 3B

Wang H, Guo L, Wang Y, Song S
Cell Cycle 2021;20(16):1527-1539

---

FNDC3B is associated with ER stress and poor prognosis in cervical cancer.

Han B, Wang H, Zhang J, Tian J
Oncology letters 2020 Jan;19(1):406-414

---

Genome-Wide Association Study Identifies a Genetic Prediction Model for Postoperative Survival in Patients with Hepatocellular Carcinoma

Wei J, Sheng Y, Li J, Gao X, Ren N, Dong Q, Qin L
Medical Science Monitor 2019;25

---

Overexpression of fibronectin type�III domain containing�3B is correlated with epithelial‑mesenchymal transition and predicts poor prognosis in lung adenocarcinoma

Bian T, Zheng L, Jiang D, Liu J, Zhang J, Feng J, Zhang Q, Qian L, Qiu H, Liu Y, Yao S
Experimental and Therapeutic Medicine 2019